Unknown NA INTERVENTIONAL 1-arm NCT05632744

Evaluation of CG-100 Intraluminal Bypass Device

Sponsor: Colospan Ltd.

Interventions CG-100 Intraluminal Bypass Device

Updated 7 times since 2022 Last updated: Feb 12, 2024 Started: Mar 15, 2023 Primary completion: Jun 15, 2024 Completion: Jun 15, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Colorectal Cancer, this trial is ongoing. The trial is conducted by Colospan Ltd. and has accumulated 7 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Mar 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2025 — Mar 2026 [monthly]

Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jan 2023 — Mar 2024 [monthly]

Not Yet Recruiting NA
Dec 2022 — Jan 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Colospan Ltd.

Data source: Colospan Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rehovot, Israel